D en D PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
D en D PHARMA
Largest movements
- Tangible fixed assets +€180,289
up €180,289 (+15.6%), from €1.2m to €1.3m
of which Plant, machinery and equipment: +€187,105
- Receivables within one year +€34,911
up €34,911 (+22.6%), from €154,424 to €189,335
of which Trade receivables: +€72,241
- Reserves +€149,163
up €149,163 (+23.5%), from €633,553 to €782,716
of which Distributable reserves: +€141,705
- Trade debts +€37,574
up €37,574 (+44.0%), from €85,325 to €122,899
- Current portion of long-term debt +€16,105
up €16,105 (+119%), from €13,522 to €29,627
- Gross operating margin +€49,275
up €49,275 (+22.5%), from €218,566 to €267,841
- Taxes +€19,654
up €19,654 (+41.8%), from €47,065 to €66,719
- Depreciation +€4,940
up €4,940 (+11.4%), from €43,468 to €48,408
- Financial charges -€2,990
down €2,990 (-61.8%), from €4,838 to €1,848
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,336,328 | €1,546,742 | +€210,414 | +15.7% |
| Fixed assets | 21/28 | €1,161,009 | €1,341,299 | +€180,289 | +15.5% |
| Tangible fixed assets | 22/27 | €1,156,009 | €1,336,299 | +€180,289 | +15.6% |
| Land and buildings | 22 | €678,059 | €671,516 | -€6,543 | -1.0% |
| Plant, machinery and equipment | 23 | €477,076 | €664,180 | +€187,105 | +39.2% |
| Furniture and vehicles | 24 | €875 | €602 | -€273 | -31.2% |
| Financial fixed assets | 28 | €5,000 | €5,000 | = | 0.0% |
| Current assets | 29/58 | €175,318 | €205,444 | +€30,125 | +17.2% |
| Amounts receivable within one year | 40/41 | €154,424 | €189,335 | +€34,911 | +22.6% |
| Trade receivables | 40 | €79,428 | €151,669 | +€72,241 | +91.0% |
| Other amounts receivable | 41 | €74,996 | €37,666 | -€37,330 | -49.8% |
| Cash at bank and in hand | 54/58 | €244 | €782 | +€538 | +221% |
| Deferred charges and accrued income | 490/1 | €20,650 | €15,327 | -€5,323 | -25.8% |
| Total equity and liabilities | 10/49 | €1,336,328 | €1,546,742 | +€210,414 | +15.7% |
| Equity | 10/15 | €1,196,853 | €1,346,016 | +€149,163 | +12.5% |
| Contributions | 10/11 | €563,300 | €563,300 | = | 0.0% |
| Capital | 10 | €563,300 | €563,300 | = | 0.0% |
| Issued capital | 100 | €563,300 | €563,300 | = | 0.0% |
| Reserves | 13 | €633,553 | €782,716 | +€149,163 | +23.5% |
| Non-distributable reserves | 130/1 | €19,988 | €27,446 | +€7,458 | +37.3% |
| Legal reserve | 130 | €19,988 | €27,446 | +€7,458 | +37.3% |
| Tax-exempt reserves | 132 | €11,600 | €11,600 | = | 0.0% |
| Distributable reserves | 133 | €601,965 | €743,670 | +€141,705 | +23.5% |
| Profit (loss) carried forward | 14 | €0 | - | = | |
| Amounts payable | 17/49 | €139,474 | €200,726 | +€61,252 | +43.9% |
| Amounts payable after more than one year | 17 | - | €1,377 | +€1,377 | |
| Financial debts | 170/4 | - | €1,377 | +€1,377 | |
| Amounts payable within one year | 42/48 | €139,474 | €199,349 | +€59,875 | +42.9% |
| Current portion of amounts payable after more than one year | 42 | €13,522 | €29,627 | +€16,105 | +119% |
| Financial debts | 43 | - | €3,566 | +€3,566 | |
| Credit institutions | 430/8 | - | €3,566 | +€3,566 | |
| Trade debts | 44 | €85,325 | €122,899 | +€37,574 | +44.0% |
| Suppliers | 440/4 | €85,325 | €122,899 | +€37,574 | +44.0% |
| Advances received on contracts in progress | 46 | €0 | - | = | |
| Taxes, remuneration and social security | 45 | €35,777 | €37,445 | +€1,668 | +4.7% |
| Taxes | 450/3 | €26,971 | €31,407 | +€4,436 | +16.4% |
| Remuneration and social security | 454/9 | €8,806 | €6,038 | -€2,768 | -31.4% |
| Other amounts payable | 47/48 | €4,851 | €5,812 | +€961 | +19.8% |
| Non-recurring operating income | 76A | €0 | - | = | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €43,468 | €48,408 | +€4,940 | +11.4% |
| Other operating charges | 640/8 | €6,356 | €6,369 | +€13 | +0.2% |
| Non-recurring operating charges | 66A | €321 | €0 | -€321 | -100% |
| Gross operating margin | 9900 | €218,566 | €267,841 | +€49,275 | +22.5% |
| Operating profit (loss) | 9901 | €168,421 | €213,063 | +€44,642 | +26.5% |
| Financial income | 75/76B | €3,898 | €4,666 | +€769 | +19.7% |
| Recurring financial income | 75 | €3,898 | €4,666 | +€769 | +19.7% |
| Financial charges | 65/66B | €4,838 | €1,848 | -€2,990 | -61.8% |
| Recurring financial charges | 65 | €4,838 | €1,848 | -€2,990 | -61.8% |
| Profit (loss) for the period before taxes | 9903 | €167,481 | €215,882 | +€48,401 | +28.9% |
| Income taxes | 67/77 | €47,065 | €66,719 | +€19,654 | +41.8% |
| Profit (loss) for the period | 9904 | €120,416 | €149,163 | +€28,747 | +23.9% |
| Profit (loss) for the period to be appropriated | 9905 | €120,416 | €149,163 | +€28,747 | +23.9% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 18 October 2026 via checked.be.